Chemo Treats Brain Cancer Patients with Help from a Virus (IMAGE)

American Association for the Advancement of Science (AAAS)

Chemo Treats Brain Cancer Patients with Help from a Virus

Caption

In an early clinical trial of brain cancer patients, a new cancer therapy dispatches a virus to infect the tumor and deliver an enzyme, which activates a chemotherapeutic prodrug. This material relates to a paper that appeared in the June 1, 2016 issue of Science Translational Medicine, published by AAAS. The paper, by T.F. Cloughesy at University of California, Los Angeles in Los Angeles, CA, and colleagues was titled, "Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma."

Credit

C. Bickel / <i>Science Translational Medicine</i> (2016)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.